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 Mycotic keratitis is an opportunistic fungal infection of
the cornea caused by either a reduction in the local defense
mechanism or by injury to the corneal epithelium. If not cor-
rectly diagnosed and treated, mycotic keratitis can result in a
marked loss of vision and eventually cause a complete perfo-
ration of the cornea. Members of the genus Fusarium are the
most frequently isolated fungi in patients with fungal kerati-
tis. Furthermore, Fusarium has increasingly been identified
in deep tissues and disseminated infections [1-3]. Despite the
known existence of many commensal fungi within the con-
junctiva sac, the cornea is not normally inflamed. However,
the mechanism by which the host can successfully defend
against invasive fungi is still unknown.
The corneal epithelium is known to be an efficient physi-
cal barrier to infections and constitutes the first line of de-
fense against microbial pathogens [4]. This is why fungal
keratitis always occurs after the epithelial integrity of the cor-
nea has been breached, exposing underlying fibroblasts [5-8].
The ability of epithelial cells to detect various pathogens and
to tailor their response to a specific pathogen is critical for the
induction of innate immunity and for the establishment of adap-
tive immune responses [9]. In addition, vasculature does not
exist in the cornea under normal conditions, and the cells and
molecules operating during early stages of the immune re-
sponse have a decisive impact on the shaping of the subse-
quent adaptive response in the cornea. Understanding the role
that epithelial cells play in immune surveillance and host de-
fense is crucial for understanding the occurrence, progression,
and diagnosis of fungal keratitis and for developing new and
effective therapies to combat this infection.
Recent studies indicate that recognition of pathogens is
largely assigned to an evolutionarily conserved family of re-
ceptors known as toll-like receptors (TLRs). These receptors
function in innate immunity via the recognition of pathogen-
associated molecular patterns [10,11]. Previous studies showed
that human corneal epithelial cells express several different
TLRs and are able to recognize various pathogens including
Gram-positive bacteria [12], Gram-negative bacteria [13,14],
and viruses [15,16]. These TLRs respond to pathogen-associ-
ated patterns such as flagellin, lipopeptides, and poly(I:C).
Recent studies have also demonstrated that toll-like receptors
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1953(TLRs) are crucial for the recognition of fungal pathogens such
as Candida albicans [17-19], Aspergillus fumigates [20-24],
and Cryptococcus neoformans [25-27]. However, no reports
have yet investigated the relationship between TLRs and
Fusarium. To better understand the innate immune response
of corneal epithelial cells to fungal infections, we investigated
the role of TLRs in immortalized human corneal epithelial
cells (HCEC) in response to inactive hyphal fragments from
Fusarium solani.
METHODS
Reagents and antibodies:  Dulbecco’s Modified Eagle Me-
dium (DMEM), F12, fetal bovine serum (FBS), and phosphate-
buffered saline (PBS) were obtained from Invitrogen-Gibco
(New York, NY). All media and cytokines used for cell cul-
ture were endotoxin minimized. Tissue culture dishes and six-
well chamber slides were from BD (New York, NY). Hydro-
cortisone was obtained from Calbiochem (Darmstant, Ger-
many). Affinity purified, monoclonal, anti-human TLR2,
TLR4, and normal mouse immunoglobulin G (IgG) were from
eBioscience (San Diego, CA). CY3-conjugated secondary
antibody was from Beyotime Biotechnology (Beyotime,
China). 2-(4-Amidinophenyl)-6-indolecarbamidine
dihydrochloride (DAPI dihydrochloride) was used to dye nu-
clei and was purchased from Beyotime. Paired antibodies for
human interleukin-6 (IL-6) and IL-8 enzyme-linked
immunosorbent assays (ELISA) were from BD. RNeasy Mini
kits were purchased from Qiagen (Valencia, CA) for RNA
extraction. RNA polymerase chain reaction (PCR) kits were
from Promega (Fitchburg, WI), and ethidium bromide, DNA
molecular size markers, and agarose were from Gene Tech
(Shanghai, China). SYBR Green PCR kits were from Applied
Biosystems (Foster City, CA).
Isolation of killed hyphal fragments:  The Fusarium solani
strain (serial number: 3.2889) was purchased from the China
General Microbiological Culture Collection Center (CGMCC,
Beijing, China). Isolation and preparation of killed hyphal frag-
ments was previously described [20,21,28]. In brief, the strains
were grown on Sabouraud glucose agar supplemented with
penicillin-streptomycin for four to seven days at 35 °C. Conidia
were harvested by gently scraping the surfaces of the slants
and suspending them in PBS. To suspend the very hydropho-
bic conidia of Fusarium solani, 0.05% Tween 80 was added
to the PBS. To remove hyphae and debris, the conidial sus-
pension was filtered through eight layers of cheesecloth.
Conidia were cultured in YAPD (2% peptone, 2% glucose,
1% yeast extract, 0.01% adenine). After 48 h, more than 95%
of blastoconidia were grown to hyphae, which were checked
by microscope. To get hyphal fragments of a uniform size,
hyphal fragments were treated with Micro Tissue Grinders and
an Ultrasonic Cell Cracker (JY92-2D; Scientz Biotechnology
Co, Ningbo, China). Hyphal fragments were then filtered
through 400 mesh grit (38 µm diameter). Hyphal fragments
were heat-killed for 15 min at 100 °C.The sterilized hyphae
were centrifuged and resuspended vigorously in PBS, con-
taining 10 mg of RNase A per ml, and incubated for 30 min at
37 °C to remove intracellular RNA. Finally, the hyphal frag-
ments were washed three times with Hank’s Buffered Salt
Solution (HBSS) and stored at -80 °C. Microscopically, the
morphology of the killed hyphal fragments (Figure 1) appeared
to be intact (20-40 µm) and were counted on a hemacytom-
eter. The killed hyphal fragments were always confirmed by
culture in Sabouraud glucose broth.
Culture of immortalized human corneal epithelial cells:
Simian virus (SV) 40 immortalized human corneal epithelial
cells (HCEC) were cultured in DMEM/F12, supplemented with
10% FBS, 5 µg/ml insulin, 0.1 mu g/ml cholera toxin, 5 ng/ml
human epidermal growth factor, and 40 µg/ml gentamicin at
37 °C under 95% humidity and 5% CO2 as described by Araki-
Sasaki et al. [29]. The cells were kindly provided by Dr. Zan
Pan (New York University, New York, NY).
Cell challenge:  The HCECs were seeded onto Labora-
tory-Tek tissue culture chamber slides for 24 h and then sub-
jected to one of the following treatments: (1) treated with hy-
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Figure 1. Morphology and size
of the killed hyphal fragments.
The killed hyphal fragments
were used to stimulate cultured
cells in the experiment. The
hyphal fragments appear to
have an intact morphology with
diameters of approximately 20-
40 µm.
1954phal fragments (cell/hyphal is equivalent to 1/1) for 48 h at 37
°C; (2) treated with hydrocortisone (10 µg/ml) for 48 h at 37
°C; or (3) incubated with hydrocortisone (10 µg/ml) for 2 h at
37 °C followed by treatment with hyphal fragments (cell/hy-
phal is equivalent to 1/1) for 48 h at 37 °C. Following treat-
ment, supernatants were collected and stored at -80 °C to evalu-
ate the release of IL-6 and IL-8. mRNA was also extracted
from cells following treatment to evaluate the expression of
TLRs.
TLR blocking experiments were conducted by incubat-
ing HCECs with monoclonal antibodies (mAbs) against TLRs.
HCECs were incubated at room temperature with anti-TLR4,
anti-TLR2, both anti-TLR4 and anti-TLR2, or IgG control
antibody for 1 h. Cells were then treated with hyphal frag-
ments for 48 h at 37 °C, and the supernatants were collected
to evaluate the releases of IL-6 and IL-8.
Reverse transcription polymerase chain reaction:  Total
RNA prepared from confluent monolayers of HCEC was used
to evaluate the expression of TLR mRNA. Qiagen RNeasy
Mini kits were used for RNA extraction. Total RNA samples
were then reverse transcribed in a final volume of 20 µl con-
taining 1 µg RNA, 50 mM Tris-HCl, 75 mM KCl, 3 mM
MgCl2, 5 mM dithiothreitol, 20 U of RNase Inhibitor, 1 µl (1
µg) random primer, 0.5 mM each dNTP, and 200 U RNase H-
free reverse transcriptase (RT; Promega). The following primer
pair was used for the analysis of GAPDH by reverse-tran-
scription polymerase chain reaction (RT-PCR): 5'-CGG AGT
CAA CGG ATT TGG TCG TAT-3' and 5'-AGC CTT CTC
CAT GGT TGG TGA AGA C-3'.The annealing temperature
of the primers was 60 °C. Each PCR was performed in a 20 µl
solution containing 1 µl RT reaction products, 10X PCR buffer
2 µl, 1.8 mM MgCl2, 0.1 mM each dNTP, 0.1 µM of upstream
primer, 0.1 µM of downstream primer, and 0.5 U Taq DNA
polymerase. A negative control (the PCR without a preceding
RT step) for each sample was run to assess whether there was
residual genomic DNA in the DNase-treated samples.
Real-time polymerase chain reaction:  Real-time PCR was
performed in an ABI PRISM 7500 Sequence Detection Sys-
tem Thermal Cycler (Applied Biosystems). Real-time PCR
was performed on a volume of 15 µl containing 1.5 µl (50 ng)
of cDNA and 13.5 µl of master mix containing 7.5 µl of mix
(SYBR Green PCR Master Mix, Applied Biosystems), 0.75
µl of each primer (10 pmol/l), and 4.5 µl of diethyl
pyrocarbonate-treated water. The primers are listed in Table
1. The program was set at 50 °C for 2 min and 95 °C for 10
min followed by 40 cycles of denaturation at 95 °C for 15 s
and annealing at 60 °C for 60 s. The melting curve was ana-
lyzed by elevating the temperature from 60 °C to 95 °C while
monitoring fluorescence. SYBR green fluorescence was moni-
tored after each elongation period. The housekeeping gene,
GAPDH, was found to be constantly expressed in cornea.
Samples were amplified with GAPDH primers for determina-
tion of the initial relative quantity of cDNA in each sample,
and all PCR products were normalized to that amount. Nega-
tive controls (without template) were produced for each run.
Samples were amplified in triplicate, averages were cal-
culated, and differences in CT data were evaluated by Sequence
Detection Software V1.3.1 (Applied Biosystems). For data
analysis, we used the comparative CT method (∆∆CT method)
with the following formula: ∆CT=CT (Target, TLR) - CT (Endo,
GAPDH). The comparative ∆∆CT calculation involved find-
ing the difference between ∆CT of treated cells and the mean
value of the ∆CT from the untreated cells. Fold increase in the
expression of specific mRNA in treated cells compared to
untreated cells was calculated as 2-(∆∆CT). Data are expressed
as RQ (relative quantity) and differences are shown in the fig-
ures as the expression ratio of the normalized target gene ac-
cording to the software results.
Immunofluorescent staining:  HCECs were seeded onto
Laboratory-Tek tissue culture chamber slides without FBS for
24 h. The cells were then washed with Hank’s Balance Salt
Solution (Invitrogen-Gibco) and stimulated with 10 µg/ml
hydrocortisone for 48 h. The slides were then fixed in 4%
paraformaldehyde for 15 min and washed with 10X Tris Buff-
ered Saline (TBS) three times for 5 min. Fixed cells were in-
cubated in blocking buffer of 5% BSA (Proliant, Ankeny, IA)
and 0.1% Triton X-100 in PBS for 30 min at room tempera-
ture. Cells were then incubated with the following dilutions
of primary antibodies for 1 h at room temperature: primary
mouse anti human TLR2 and four monoclonal antibodies (20
µg/ml in 5% BSA-PBS) or with mouse IgG (control). The
secondary antibodies that were conjugated to Cy3 were di-
luted 1:200 in 5% BSA-PBS and incubated for 1 h at room
temperature. Coverslips were washed three times in PBS for
5 min, mounted (Vectashield; Vector Laboratories, Burlingame,
CA), and viewed with a fluorescence microscope (Zeiss mi-
croscope Imager Z1; Zeiss, Oberkochen, Germany). The DNA-
intercalating dye, DAPI dihydrochloride, was used to stain
nuclei. For the negative control, preimmune mouse serum was
substituted for the primary antibody.
Western blot:  Cells challenged with hyphal fragments
were lysed in radioimmunoprecipitation (RIPA) buffer (150
mM NaCl, 100 mM Tris-HCl [pH 7.5], 1% deoxycholate, 0.1%
sodium dodecyl sulfate [SDS], 1% Triton X-100, 50 mM NaF,
100 mM sodium pyrophosphate, 3.5 mM sodium
orthovanadate, proteinase inhibitor cocktails, and 0.1 mM
phenylmethylsulfonyl fluoride [PMSF]). Protein concentra-
tion was determined using the bicinchoninic acid (BCA) as-
say (Micro BCA; Pierce Biotechnology, Rockford, IL). Equal
amounts of protein were mixed with SDS-PAGE protein load-
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TABLE 1. PRIMERS FOR REAL-TIME POLYMERASE CHAIN REACTION
                                                                         Amplicon
Target                                                                     size
 gene     Locus     Forward sequence(5'-3')   Reverse sequence (5'-3')     (bp)
------   --------   -----------------------   ------------------------   --------
TLR1     NM003263   GCCCAAGGAAAAGAGCAAAC      AAGCAGCAATATCAACAGGAG        135
TLR2     NM003264   TCTCCCATTTCCGTCTTTTT      GGTCTTGGTGTTCATTATCTTC       125
TLR3     NM003265   TAAACTGAACCATGCACTCT      TATGACGAAAGGCACCTATC         101
TLR4     NM003266   GAAGCTGGTGGCTGTGGA        GATGTAGAACCCGCAAG            213
TLR5     NM003268   TTGCTCAAACACCTGGACAC      CTGCTCACAAGACAAACGAT         148
TLR6     NM006068   GTGCCATTACGAACTCTA        TTGTTGGGAATGCTGTT            109
TLR7     NM016562   CTGACCACTGTCCCTGAG        AACCCACCAGACAAACCA           263
TLR8     NM016610   AACATCAGCAAGACCCAT        GACTCCTTCATTCTCCCT            64
TLR9     NM017442   CGCCAACGCCCTCAAGACA       GGCGCTTACATCTAGTATTTGC        79
TLR10    NM030956   CTCCCAACTTTGTCCAGAAT      GGTGGGAATGCAATAGAAT          132
GAPDH               CCCCACACACATGCACTTACC     TTGCCAAGTTGCCTGTCCTT         100
Specific primers for TLR1-10 mRNAs were designed using Prime 3
software, possibly to be 1-intron spanning.
1955ing buffer and boiled for 5 min. Proteins were separated by
sodium dodecyl sulfate-PAGE in Tris/glycine/SDS buffer (25
mM Tris, 250 mM glycine, and 0.1% SDS) and electro-blot-
ted onto nitrocellulose transfer membranes. After blocking with
5% nonfat milk for 1 h, membranes were washed three times
with TBST for 5 min and incubated overnight with polyclonal
antibodies against TLR2 and TLR4 (1:1000 dilution in 5%
nonfat milk) in TBST. GAPDH was used as the control. After
washing three times in TBST, membranes were incubated with
secondary HRP-conjugated anti-mouse IgG for 1 h. The mem-
branes were again washed with TBST three times and one
time in TBS, 5 min each. Immune complexes were visualized
with an enhanced chemiluminescence reagent (Pierce). Re-
sults were quantified by capturing the exposed X-ray film
image and using area measurements from image analysis soft-
ware.
Enzyme-linked immunosorbent assay:  The concentrations of
IL-6 and IL-8 in the cell culture supernatants were determined
by ELISA. The assay was performed according to
manufacturer’s instructions. Results from two representative
experiments are presented as the means±SEM of triplicate
cytokine measurements.
Statistical analysis:  Data are expressed as mean±SEM
of triplicates from experiments repeated three times that yielded
similar results. Statistical significance of differences was de-
termined with the nonparametric Wilcoxon test and Student’s
t test using SPSS (version 11.5). Differences were considered
statistically significant at p<0.05.
RESULTS
Expression of toll-like receptors 1-10 mRNAs in human
corneal epithelial cells:  Preliminary studies using real time
PCR revealed that HCEC expressed varying levels of mRNA
for TLR1-10 (Figure 2). TLR1, 3, 4, and 5 were expressed at
relatively higher levels in HCECs relative to the other TLRs.
Modulation of toll-like receptor mRNA expression by hy-
phal fragments from Fusarium solani: The results of real time
PCR indicated that inactive hyphal fragments treatment can
increase the mRNA expression of TLR2, 3, 4, and 6 in cul-
tured HCEC (Figure 3).
Hydrocortisone can modulate the expression of toll-like
receptor mRNA in human corneal epithelial cells:  The results
of real time PCR showed that hydrocortisone treatment
upregulated the expression of TLR2, 4, 6, and 10 mRNA in
HCECs (Figure 4). The increased transcription of TLR2 and
TLR4 was especially pronounced. Hydrocortisone also in-
creased mRNA expression of TLR 2, 4, 9, and 10 in the pres-
ence of hyphal fragments (Figure 5).
Increased expression of toll-like receptor 2 and 4 protein
following hyphal fragment treatment:  The results of immun-
ofluorescence staining revealed moderate TLR2 and 4 reac-
tivity in untreated HCECs. The staining intensity of these an-
tigens was slightly enhanced after treatment with hyphal frag-
ments (Figure 6).
The expressions of TLR2 and TLR4 were also confirmed
by western blot analysis. The results of this analysis demon-
strated increased expressions of TLR2 and TLR4 following
treatment with hyphal fragments (Figure 7). The expressions
of TLR2 and TLR4 proteins following treatment with hyphal
fragments were further enhanced by cotreatment with hydro-
cortisone (Figure 7).
Increased release of IL-6 and IL-8 in human corneal epi-
thelial cells treated with hyphae fragments:  Results demon-
strate that treatment with hyphal fragments increased the re-
lease of IL-6 and IL-8 from HCECs (Figure 8). Hydrocorti-
sone further promoted the release of IL-6 in HCECs treated
with hyphal fragments and inhibited the release of IL-8(Fig-
ure 8). The results of ELISA assays showed that pretreatment
of HCECs with anti-TLR2 or anti-TLR4 inhibited the pro-
duction of IL-6 and IL-8 following exposure to Fusarium hy-
phae. In contrast, an isotype-matched control, Ab, had no ef-
fect on IL-6 or IL-8 production (Figure 8). Maximal inhibi-
tion was observed in HCECs treated with antibodies against
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Figure 2. Real time PCR shows the relative expression of TLR1-10
mRNA.  The TLR8 mRNA is regarded as the standard control (RQ=1).
Expression of the other TLRs is expressed relative to TLR8. Note
that the relative quantity (RQ) is inverted so that higher histogram
bars represent higher levels of mRNA expression. Bars represent
mean±SEM of three healthy corneas.
Figure 3. Toll-like receptors 1-10 mRNA expression in hyphal frag-
ment-treated human corneal epithelial cells compared with untreated
human corneal epithelial cells.  The expression of each TLR in un-
treated HCEC is regarded as the standard control (RQ=1), and the
TLRs in HCECs treated with hyphal fragments are expressed as the
multiple of the untreated HCECs. Bars represent mean±SEM of three
independent experiments. The asterisk represents p<0.05 versus con-
trol.
1956both TLR2 and TLR4 with a 78% reduction in IL-6 and a
84% reduction in IL-8. In comparison, incubation with TLR2
mAb alone inhibited hyphal-induced IL-6 and IL-8 by 68%
and 62%, respectively, while incubation with TLR4 mAb alone
inhibited hyphal-induced IL-6 and IL-8 by 53% and 56%, re-
spectively.
DISCUSSION
 A critical component of host defenses against microbes is the
ability of the immune system to recognize and respond to for-
eign invaders. Recent studies have established the central role
of TLRs in innate immune recognition of a wide variety of
microbial pathogens [30-32]. The current study assessed the
contribution of TLR2 and TLR4 to signaling in response to
the opportunistic fungus Fusarium solani. We demonstrated
that hyphal fragments from Fusarium solani increased the
expression of TLR2, 3, 4, and 6 mRNAs and the release of IL-
6 and IL-8. The expressions of TLR2 and TLR4 proteins were
also enhanced by exposure to hyphal fragments. The release
of IL-6 and IL-8 was also inhibited by pretreatment with anti-
TLR2 and anti-TLR4 monoclonal antibodies. Our data sug-
gest that both TLR2 and TLR4 contribute to signaling re-
sponses following exposure to Fusarium solani.
Corneal epithelial cells are constantly exposed to micro-
bial pathogens and their products on the ocular surface. Al-
though the cornea is highly resistant to infections under nor-
mal conditions, sight-threatening microbial infections may
occur when the corneal integrity is breached by trauma or con-
tact lens wear. Therefore, the underlying mechanisms that regu-
late corneal epithelial cell activation are important in the de-
velopment of infectious keratitis. Previous reports showed that
human corneal epithelial cells express functionally active
TLR2, 3, and 5 and that these cells respond to Staphylococcus
aureus, poly(I:C), and Pseudomonas aeruginosa and their
products, respectively [12-16]. The current study is the first to
study the involvement of TLRs in the host response to
Fusarium. The results of this study demonstrated that expo-
sure of HCECs to inactive hyphal fragment resulted in the
upregulation of TLR mRNA expression of TLR2, 3, 4, and 6.
This study focused on TLR2 and TLR4 because TLR3
reportedly only responds to double-stranded (ds) RNA [33,34]
and TLR6 mainly recognizes its ligands as a heterodimer with
TLR2 [35]. TLR6/TLR2 heterodimers can recognize lipopro-
teins [35] and peptidoglycan [36]; however, TLR6 has never
been reported to play an independent role in the innate im-
mune response. Furthermore, TLR2 and TLR4 have previ-
ously been reported to mediate host response to other fungi
such as candidiasis, Aspergillus, and Cryptococcus neoformans
[17-27].
Results from this study indicated that both TLR2 and
TLR4 are likely involved in the host response to Fusarium in
HCECs. Our results are in agreement with other reports in-
vestigating host response to other fungal pathogens. Netea [17]
demonstrated that the absence of TLR4-mediated signals re-
sulted in an increased susceptibility to disseminated candidi-
asis in TLR4-defective mice. Experimental models of dissemi-
nated candidiasis infection in TLR2-/- mice have also shown
modulatory effects of TLR2 on host defense [18,19]. Wang
[20] proposed that TLR4 but not TLR2 functions as a receptor
for Aspergillus hyphae. However, other reports have demon-
strated that both TLR2 and TLR4 are important for recogni-
tion of Aspergillus fumigatus [21-24] and Aspergillus niger
[23]. Other reports have demonstrated that Cryptococcus
neoformans glucuronoxylomannan binds to TLR2 and TLR4,
resulting in translocation of NF-κB caused by the binding of
TLR4 but not of TLR2 [25]. More recently MyD88 and TLR2
but not TLR4 were shown to be required for host defense
against Cryptococcus neoformans infection [26,27].
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Figure 4. Toll-like receptors 1-10 mRNA expression in hydrocorti-
sone treated human corneal epithelial cells compared with untreated
human corneal epithelial cells.  The expression of each TLR in un-
treated HCECs is regarded as the standard control (RQ=1), and the
TLR expression in hydrocortisone-treated HCECs is expressed as
the multiple of the expression of HCEC. Bars represent mean±SEM
of three independent experiments. The asterisk represents p<0.05
versus control. Hydro: hydrocortisone.
Figure 5. Toll-like receptors 1-10 mRNA expression in hydrocorti-
sone and hyphal fragments-treated human corneal epithelial cells
compared with levels in human corneal epithelial cells treated with
hyphal fragments alone.  The expression of each TLR in hyphal frag-
ments-treated HCECs is regarded as the standard control (RQ=1),
and the TLRs in both hydrocortisone and hyphal fragments-treated
HCEC is expressed as the multiple of the TLR expression in HCECs
treated with hyphal fragments alone, Bars represent mean±SEM of
three independent experiments. The asterisk represents p<0.05 ver-
sus control. Hydro: hydrocortisone.
1957Glucocorticoids are widely recognized as regulators of
adaptive immunity and inflammation. These compounds have
been used extensively in clinical settings to suppress a large
variety of inflammatory and immune responses. Topical cor-
ticosteroids have evolved into the standard treatment for nearly
every inflammatory disease of the ocular anterior segment
[37,38] and can enhance the invasive abilities of fungi [39].
Despite the importance of glucocorticoids in suppressing im-
mune and inflammatory responses, their role in enhancing host
immune and defense responses against invading microbial
pathogens is poorly understood. Recent studies by Silverstein
[40] and Imasato [41] surprisingly indicate that glucocorti-
coids could enhance epithelial expression of TLR2 in cultured
cells by nontypeable Hemophilus influenzae through activa-
tion of TLR2 itself [41,42]. This result has recently been con-
firmed by Homma [43] and suggests that glucocorticoids may
enhance the sensitivity of the epithelial surface to TLR ligands
in some cases. Therefore, we next investigated whether hy-
drocortisone can modulate transcription of TLRs in HCECs
induced by hyphal fragments. Interestingly, our results showed
that hydrocortisone upregulated TLR mRNA especially TLR2
and TLR4. We also demonstrated that TLR2 and TLR4 pro-
tein expression was increased in response to hyphal fragments.
The results indicate that glucocorticoids enhance the expres-
sion of the TLRs on the epithelium and may benefit by inhib-
iting fungal infections in the epithelium. Thus, it appears that
glucocorticoids may not only suppress but also enhance host
immune and defense response. In addition, our study may also
provide the molecular basis to explain the beneficial role of
glucocorticoids in certain cornea infections. However, the exact
molecular mechanisms by which glucocorticoids enhance TLR
expression in HCECs and contribute to host immune and de-
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Figure 6. The hyphae fragments-stimulated cells treated with anti-TLR2 and anti-TLR4 antibodies and stained by Cy3 and 2-(4-Amidinophenyl)-
6-indolecarbamidine dihydrochloride.  There was no immunoreactivity in the negative control (isotype IgG). Merge means overlap with the
DAPI and Cy3.
1958fense responses remain to be fully elucidated. The synergistic
enhancement of TLR expression by glucocorticoids probably
contributes to the accelerated immune response of epithelial
cells as well as resensitization of epithelial cells to invading
pathogens. If so, upregulation of TLRs may be one of the posi-
tive immune-regulatory mechanisms involved in glucocorti-
coid-mediated host defense against many pathogens. In this
study, we showed that hydrocortisone can upregulate transcrip-
tion of TLRs, especially in TLR2 and TLR4, regardless of
treatment with hyphal fragments (Figure 4 and Figure 5). The
results indicate that the hydrocortisone may enhance the anti-
fungal infection immune response of the host by increasing
expression of TLRs. Therefore, our study may provide new
insights into the role of glucocorticoids in innate immune func-
tions.
Recognition of pathogen-associated molecular patterns
(PAMPs) via TLRs can lead to translocation of the nuclear
factor NF-κB, resulting in upregulation of proinflammatory
cytokines, costimulatory molecules, and chemokines [44,45]
such as TNF-α, IL-6, IL-8, IL-18, and monocyte chemotactic
protein-1 (MCP). Furthermore, the fact that hyphal fragments
induce cytokine production in several leukocyte subsets sup-
ports the contention that cytokines play important roles in the
host’s defense against fungal pathogens [46-48]. In this study,
we investigated IL-6 and IL-8 secretion to determine whether
the expressions of TLR2 and TLR4 play functional roles. We
found that activation of TLRs in response to Fusarium solani
hyphal fragments resulted in the production of IL-8, the ma-
jor chemokine that attracts polymorphonuclear leukocytes
(PMNs) into the infected cornea, and IL-6, which activates
PMNs. A similar study also reported poly (I:C) [16] and li-
popolysaccharides (LPS) [49] induced IL-6 and IL-8 expres-
sion in human corneal epithelial cells. Therefore, in response
to an invading fungal pathogen, HCECs have the capability to
recruit PMNs, which are known to be essential in preventing
and restricting fungal infection in the cornea.
At the same time, we observed that hydrocortisone can
enhance the release of IL-6. This enhancement apparently cor-
relates with the increased levels of the TLR mRNA following
hydrocortisone treatment. These results suggested that the
action of hydrocortisone on the cornea may be partially medi-
ated via TLRs.
Treatment with hyphal fragments resulted in upregulation
of TLR2 and TLR4 and increased the release of IL-6 and IL-
8. Therefore, we investigated whether blocking TLR2 and
TLR4 with specific monoclonal antibodies (mAbs) can affect
the release of IL-6 and IL-8 in HCECs following treatment
with hyphal fragments. The results of ELISA showed that pre-
treatment of HCEC with anti-TLR2 or anti-TLR4 inhibited
the production of IL-6 and IL-8 induced by Fusarium hyphae
while an isotype-matched control Ab was ineffective (Figure
7). Maximal inhibition levels were obtained with both TLR2
and TLR4 mAb. Our findings suggest that signaling in re-
sponse to hyphal fragments is mediated via both TLR2 and
TLR4 in HCECs and that TLR2 may play a greater role than
TLR4.
Extrapolation of results in HCECs to the in vivo corneal
epithelium may be problematic due to inherent differences be-
tween the two systems. For example, transformation by SV40
may significantly affect the expression of TLRs. However,
previous studies have shown that HCECs are an excellent cell
line in which to study TLR function in the corneal epithelium.
The functions of TLRs in response to pathogen-associated
patterns such as flagellin, lipopeptides, and poly(I:C) in HCECs
are similar to the functions of TLRs in cultured primary hu-
man corneal epithelial cells [12,13,15,50].
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Figure 8. The results of ELISA showed the release of IL-6 and IL-8
from HCEC under different stimulation.  Data are the mean±SEM of
triplicates from an experiment that was repeated three times with
similar results. The asterisk represents p<0.05 versus the correspond-
ing value for cells incubated with hyphal fragments. HF: hyphal frag-
ments; 10-Hydro: hydrocortisone (10 µg/ml); TLR2/4: combined use
of TLR2 and TLR4.
Figure 7. Western blot analyses detect the expression of TLR2 and
TLR4 proteins in human corneal epithelial cells following different
stimulation.  Equal amounts of total protein were loaded. The results
demonstrated the upregulated expressions of TLR2 and TLR4 under
the treatment of hyphal fragments. This upregulation can be further
enhanced by hydrocortisone. The results are representative of three
independent experiments. Con: control; HF: hyphal fragments; Hy-
dro: hydrocortisone.
1959In summary, our data suggest that TLRs are involved in
the cornea response to invasive fungal infections. TLR2 and
TLR4 may play crucial roles in signaling in response to
Fusarium hyphae in HCECs. Glucocorticoids enhance the
expression of the TLRs on the epithelium and may promote
resistance to fungal infections in the epithelium. These find-
ings may provide crucial information for understanding the
immune mechanisms of fungal keratitis and help design new
immune therapeutical approaches to fungal keratitis.
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